Magellan Health (NASDAQ:MGLN) Downgraded to Sell at BidaskClub
MGLN has been the topic of several other reports. ValuEngine upgraded shares of Magellan Health from a “sell” rating to a “hold” rating in a report on Wednesday, February 20th. Zacks Investment Research upgraded shares of Magellan Health from a “sell” rating to a “hold” rating in a report on Tuesday, February 12th. Finally, Bank of America initiated coverage on shares of Magellan Health in a report on Friday, February 22nd. They set a “buy” rating and a $84.00 price objective on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $74.80.
NASDAQ:MGLN opened at $64.82 on Tuesday. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 26.57, a PEG ratio of 0.70 and a beta of 0.52. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.62 and a current ratio of 1.67. Magellan Health has a 12-month low of $51.88 and a 12-month high of $99.90.
Several hedge funds have recently made changes to their positions in MGLN. PNC Financial Services Group Inc. purchased a new position in shares of Magellan Health during the 4th quarter worth about $44,000. Financial Gravity Companies Inc. acquired a new stake in Magellan Health during the 4th quarter worth approximately $47,000. FNY Investment Advisers LLC acquired a new stake in Magellan Health during the 1st quarter worth approximately $52,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Magellan Health by 22.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,831 shares of the company’s stock worth $104,000 after purchasing an additional 332 shares in the last quarter. Finally, Pearl River Capital LLC acquired a new stake in Magellan Health during the 4th quarter worth approximately $132,000. Institutional investors and hedge funds own 98.38% of the company’s stock.
Magellan Health Company Profile
Magellan Health, Inc provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine.
Read More: Retained Earnings
Receive News & Ratings for Magellan Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health and related companies with MarketBeat.com's FREE daily email newsletter.